Analysts Are Bullish on Top Healthcare Stocks: Calliditas Therapeutics (CALT), Aclarion, Inc. (ACON)
Aclarion, Inc. (ACON) Receives a Buy From Maxim Group
Maxim Group Sticks to Its Buy Rating for Aclarion, Inc. (ACON)
Aclarion Price Target Announced at $3.00/Share by Maxim Group
Aclarion Initiated at Buy by Maxim Group
Maxim Group Initiates Coverage On Aclarion with Buy Rating, Announces Price Target of $3
Aclarion analyst ratings
Maxim Starts Aclarion at Buy With $3 Price Target
No Data